Jay Modi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jay Modi has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Griffin K. Hughes
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, USA
5 shared publications - Kyle Fitzgerald
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma, USA
5 shared publications - Matt Vassar
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, USA
5 shared publications - Trevor Magee
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK, United States
5 shared publications - Alicia Ito Ford
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, USA
4 shared publications - Garrett Jones
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, USA
4 shared publications
Latest Publications
- Open Access
- 15 August 2024
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 41, 101347
Assessing core outcome set uptake in randomized controlled trials for chronic kidney disease: Cross-sectional analysis
- 15 August 2024
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 41, 101347
Open AccessAssessing core outcome set uptake in randomized controlled trials for chronic kidney disease: Cross-sectional analysis
- 5 June 2024
- Published by Springer Nature in Quality of Life Research
- Vol. 33 (8) , 2275-2283
Assessing uptake of the core outcome set in anxiety disorder clinical trials: a cross-sectional analysis
- 5 June 2024
- Published by Springer Nature in Quality of Life Research
- Vol. 33 (8) , 2275-2283
Assessing uptake of the core outcome set in anxiety disorder clinical trials: a cross-sectional analysis
- 23 February 2024
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 32 (6) , 713-718
Assessing the degree to which randomized controlled trials align with the core outcome set for osteoarthritis of knee and hip: A cross-sectional analysis
- 23 February 2024
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 32 (6) , 713-718
Assessing the degree to which randomized controlled trials align with the core outcome set for osteoarthritis of knee and hip: A cross-sectional analysis
- 7 January 2024
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 207, 111085
Assessing the uptake of the type 1 diabetes core outcome set in randomized controlled trials: A Cross-Sectional study
- 7 January 2024
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 207, 111085
Assessing the uptake of the type 1 diabetes core outcome set in randomized controlled trials: A Cross-Sectional study
- 20 October 2023
- Published by Springer Nature in Rheumatology International
- Vol. 44 (5) , 909-917
Endorsement of reporting guidelines and clinical trial registration across Scopus-indexed rheumatology journals: a cross-sectional analysis
The purpose of this study was to investigate the instructions for authors of rheumatology journals and analyze their endorsement of reporting guidelines and clinical trial registration. Sixty rheumatology journals were selected by a research librarian and an investigator through the 2021 Scopus CiteScore tool. The instructions for authors’ subsection of each journal was assessed to determine endorsement of study design-specific reporting guidelines or clinical trial registration. Descriptive statistics were calculated using R (version 4.2.1) and RStudio. Of the 58 journals analyzed, 34 (34/58; 59%) mentioned the EQUATOR Network: an online compendium of best practice reporting guidelines. The most commonly mentioned reporting guidelines were CONSORT with 44 journals (44/58; 75%), and PRISMA with 35 journals (35/58; 60%). The least mentioned guidelines were QUOROM with 56 journals not mentioning the guideline (56/58; 97%), and SRQR with 53 journals not mentioning the guideline (53/57, 93%). Clinical trial registration was required by 38 journals (38/58; 66%) and recommended by 8 journals (8/58; 14%). Our study found that endorsement of reporting guidelines and clinical trial registration within rheumatology journals was suboptimal with great room for improvement. Endorsement of reporting guidelines have shown to not only mitigate bias, but also improve research methodologies. Therefore, we recommend rheumatology journals broadly expand their endorsement of reporting guidelines and clinical trial registration to improve the quality of evidence they publish.
- 20 October 2023
- Published by Springer Nature in Rheumatology International
- Vol. 44 (5) , 909-917
Endorsement of reporting guidelines and clinical trial registration across Scopus-indexed rheumatology journals: a cross-sectional analysis
The purpose of this study was to investigate the instructions for authors of rheumatology journals and analyze their endorsement of reporting guidelines and clinical trial registration. Sixty rheumatology journals were selected by a research librarian and an investigator through the 2021 Scopus CiteScore tool. The instructions for authors’ subsection of each journal was assessed to determine endorsement of study design-specific reporting guidelines or clinical trial registration. Descriptive statistics were calculated using R (version 4.2.1) and RStudio. Of the 58 journals analyzed, 34 (34/58; 59%) mentioned the EQUATOR Network: an online compendium of best practice reporting guidelines. The most commonly mentioned reporting guidelines were CONSORT with 44 journals (44/58; 75%), and PRISMA with 35 journals (35/58; 60%). The least mentioned guidelines were QUOROM with 56 journals not mentioning the guideline (56/58; 97%), and SRQR with 53 journals not mentioning the guideline (53/57, 93%). Clinical trial registration was required by 38 journals (38/58; 66%) and recommended by 8 journals (8/58; 14%). Our study found that endorsement of reporting guidelines and clinical trial registration within rheumatology journals was suboptimal with great room for improvement. Endorsement of reporting guidelines have shown to not only mitigate bias, but also improve research methodologies. Therefore, we recommend rheumatology journals broadly expand their endorsement of reporting guidelines and clinical trial registration to improve the quality of evidence they publish.
- 27 September 2023
- Published by Elsevier in Ageing Research Reviews
- Vol. 91, 102081
Assessing uptake of the core outcome set in randomized controlled trials for Parkinson’s disease: A systematic review
- 27 September 2023
- Published by Elsevier in Ageing Research Reviews
- Vol. 91, 102081
Assessing uptake of the core outcome set in randomized controlled trials for Parkinson’s disease: A systematic review
- 27 September 2022
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 129 (5) , 767-775
An analysis of harms reporting in systematic reviews regarding ketorolac for management of perioperative pain
- 27 September 2022
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 129 (5) , 767-775
An analysis of harms reporting in systematic reviews regarding ketorolac for management of perioperative pain